搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Geobacter metallireducens 4-hydroxythreonine-4-phosphate dehydrogenase (pdxA) CSB-YP662586GBJ
CSB-EP662586GBJ
CSB-BP662586GBJ
CSB-MP662586GBJ
CSB-EP662586GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens NADH-quinone oxidoreductase subunit B (nuoB) CSB-YP662587GBJ
CSB-EP662587GBJ
CSB-BP662587GBJ
CSB-MP662587GBJ
CSB-EP662587GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Adenylosuccinate synthetase (purA) CSB-YP662588GBJ
CSB-EP662588GBJ
CSB-BP662588GBJ
CSB-MP662588GBJ
CSB-EP662588GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Ribosomal protein S12 methylthiotransferase RimO (rimO) CSB-YP662589GBJ
CSB-EP662589GBJ
CSB-BP662589GBJ
CSB-MP662589GBJ
CSB-EP662589GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Glycogen synthase 2 (glgA2) CSB-YP662590GBJ
CSB-EP662590GBJ
CSB-BP662590GBJ
CSB-MP662590GBJ
CSB-EP662590GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens tRNA pseudouridine synthase D (truD) CSB-YP662591GBJ
CSB-EP662591GBJ
CSB-BP662591GBJ
CSB-MP662591GBJ
CSB-EP662591GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Thiazole synthase (thiG) CSB-YP662592GBJ
CSB-EP662592GBJ
CSB-BP662592GBJ
CSB-MP662592GBJ
CSB-EP662592GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Ribonuclease HII (rnhB) CSB-YP662593GBJ
CSB-EP662593GBJ
CSB-BP662593GBJ
CSB-MP662593GBJ
CSB-EP662593GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens 50S ribosomal protein L9 (rplI) CSB-YP662594GBJ
CSB-EP662594GBJ
CSB-BP662594GBJ
CSB-MP662594GBJ
CSB-EP662594GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Chemotaxis response regulator protein-glutamate methylesterase 4 (cheB4) CSB-YP662595GBJ
CSB-EP662595GBJ
CSB-BP662595GBJ
CSB-MP662595GBJ
CSB-EP662595GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Chaperone protein htpG (htpG), partial CSB-YP662596GBJ
CSB-EP662596GBJ
CSB-BP662596GBJ
CSB-MP662596GBJ
CSB-EP662596GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Chemotaxis response regulator protein-glutamate methylesterase 3 (cheB3) CSB-YP662597GBJ
CSB-EP662597GBJ
CSB-BP662597GBJ
CSB-MP662597GBJ
CSB-EP662597GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Tetraacyldisaccharide 4'-kinase (lpxK) CSB-YP662598GBJ
CSB-EP662598GBJ
CSB-BP662598GBJ
CSB-MP662598GBJ
CSB-EP662598GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Leucine--tRNA ligase (leuS), partial CSB-YP662599GBJ
CSB-EP662599GBJ
CSB-BP662599GBJ
CSB-MP662599GBJ
CSB-EP662599GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP662600GBJ
CSB-EP662600GBJ
CSB-BP662600GBJ
CSB-MP662600GBJ
CSB-EP662600GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP662601GBJ
CSB-EP662601GBJ
CSB-BP662601GBJ
CSB-MP662601GBJ
CSB-EP662601GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens UPF0345 protein Gmet_1778 (Gmet_1778) CSB-YP662602GBJ
CSB-EP662602GBJ
CSB-BP662602GBJ
CSB-MP662602GBJ
CSB-EP662602GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (gpmA) CSB-YP662603GBJ
CSB-EP662603GBJ
CSB-BP662603GBJ
CSB-MP662603GBJ
CSB-EP662603GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Phosphate acyltransferase (plsX) CSB-YP662604GBJ
CSB-EP662604GBJ
CSB-BP662604GBJ
CSB-MP662604GBJ
CSB-EP662604GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter metallireducens Biotin synthase (bioB) CSB-YP662605GBJ
CSB-EP662605GBJ
CSB-BP662605GBJ
CSB-MP662605GBJ
CSB-EP662605GBJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>